48 related articles for article (PubMed ID: 30547773)
41. Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.
Lin Z; Liu J; Peng L; Zhang D; Jin M; Wang J; Xue J; Liu H; Zhang T
BMC Cancer; 2018 Dec; 18(1):1253. PubMed ID: 30547773
[TBL] [Abstract][Full Text] [Related]
42. Current options for the management of rectal cancer.
O'Neil BH; Tepper JE
Curr Treat Options Oncol; 2007 Oct; 8(5):331-8. PubMed ID: 18181024
[TBL] [Abstract][Full Text] [Related]
43. [Difference of colon cancer and rectal cancer-from the view of an oncological physician].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):321-3. PubMed ID: 20723426
[No Abstract] [Full Text] [Related]
44. Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis.
Yang YJ; Cao L; Li ZW; Zhao L; Wu HF; Yue D; Yang JL; Zhou ZR; Liu SX
Oncotarget; 2016 Jul; 7(29):45513-45524. PubMed ID: 27322422
[TBL] [Abstract][Full Text] [Related]
45. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
[TBL] [Abstract][Full Text] [Related]
46.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
